A Study to Assess LY01005 Versus Goserelin Comparator (ZOLADEX®) in Patients With Prostate Cancer

Clinical trial NCT03450109 · COMPLETED

Trial details

NCT number: NCT03450109
Sponsor: Luye Pharma Group Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cancer of Prostate

Start date: 2017-12-22
Primary completion: 2018-10-15
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.